GFAP and sleep disorder: Some studies revealed the potential utilization of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) concentration levels as biomarkers of sleep disorder and daytime drowsiness, as well as their roles in predicting decline in neurodegeneration and cognitive performance.10, 11